Direct Oral Anticoagulants (DOAC): Are We Ready for a Pharmacogenetic Approach?

Published in: Journal of personalized medicine (2021)

Anticoagulants play an important role in reducing complications and mortality associated with thromboembolic disorders, and anticoagulant therapy has been progressively enriched over the last few years with numerous new options [...].

Keyphrases

direct oral anticoagulants
atrial fibrillation
venous thromboembolism
risk factors
cardiovascular events
type diabetes
coronary artery disease
mesenchymal stem cells
cell therapy
smoking cessation